159 related articles for article (PubMed ID: 12942572)
1. Differential gene expression in leiomyosarcoma.
Skubitz KM; Skubitz AP
Cancer; 2003 Sep; 98(5):1029-38. PubMed ID: 12942572
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression in uterine leiomyoma.
Skubitz KM; Skubitz AP
J Lab Clin Med; 2003 May; 141(5):297-308. PubMed ID: 12761473
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
4. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
Gannon BR; Manduch M; Childs TJ
Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
6. Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization.
Larramendy ML; Kaur S; Svarvar C; Böhling T; Knuutila S
Cancer Genet Cytogenet; 2006 Sep; 169(2):94-101. PubMed ID: 16938566
[TBL] [Abstract][Full Text] [Related]
7. Expression profile of several genes in human myometrium and uterine leiomyoma.
Roth TM; Klett C; Cowan BD
Fertil Steril; 2007 Mar; 87(3):635-41. PubMed ID: 17173903
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display.
Pambuccian CA; Oprea GM; Lakatua DJ
Gynecol Oncol; 2002 Mar; 84(3):431-6. PubMed ID: 11855883
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
12. Microarray study of gene expression in uterine leiomyoma.
Litovkin KV; Ivanova OV; Bauer A; Hoheisel JD; Bubnov VV; Zaporozhan VN
Exp Oncol; 2008 Jun; 30(2):106-11. PubMed ID: 18566572
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression identifies subgroups of renal cell carcinoma.
Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
[TBL] [Abstract][Full Text] [Related]
14. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
15. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
Atkins KA; Arronte N; Darus CJ; Rice LW
Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB
Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
[TBL] [Abstract][Full Text] [Related]
18. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
19. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]